Iterum Therapeutics Plc Overview

Iterum Therapeutics Plc Other Income Expense Net

Other Income/Expense Net for ITRM.

Quarterly Other Income/Expense

-$1.47M

As of Sep 30, 2025

Annual Other Income/Expense (TTM)

-$6.39M

↓ 139.57% YoY

Trailing 12 months ending Sep 30, 2025

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin